SRY and OCT4 Are Required for the Acquisition of Cancer Stem Cell-Like Properties and Are Potential Differentiation Therapy Targets

Ovarian cancer stem-like cells with induced translineage-differentiation capacity and are suppressed by alkaline phosphatase inhibitor

(2015) Kuei-Chun Liu et al.   Oncotarget

Growth arrest and forced differentiation of human primary glioblastoma multiforme by a novel small molecule

(2014) Tae-Wook Kang et al.   Scientific Reports

Sex-Dependent Gene Expression in Human Pluripotent Stem Cells

(2014) Daniel Ronen et al.   Cell Reports

Tumour heterogeneity and cancer cell plasticity

(2013) Corbin E. Meacham et al.   NATURE

The male-specific factor Sry harbors an oncogenic function

(2013) S Murakami et al.   ONCOGENE

Targeting Neuroblastoma Stem Cells with Retinoic Acid and Proteasome Inhibitor

(2013) Barbara Hämmerle et al.   PLoS One

BMP4 Administration Induces Differentiation of CD133+Hepatic Cancer Stem Cells, Blocking Their Contributions to Hepatocellular Carcinoma

(2012) Lixing Zhang et al.   CANCER RESEARCH

Hyaluronan-CD44v3 Interaction with Oct4-Sox2-Nanog Promotes miR-302 Expression Leading to Self-renewal, Clonal Formation, and Cisplatin Resistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma

(2012) Lilly Y. W. Bourguignon et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Deregulated MYC expression induces dependence upon AMPK-related kinase 5

(2012) Lidan Liu et al.   NATURE

Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming

(2012) X Zhang et al.   ONCOGENE

Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation

(2012) S M Kumar et al.   ONCOGENE

Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression

(2011) Federica Gambelli et al.   CELL BIOLOGY INTERNATIONAL

Induced Neuronal Cells: How to Make and Define a Neuron

(2011) Nan Yang et al.   Cell Stem Cell

Sgf29 binds histone H3K4me2/3 and is required for SAGA complex recruitment and histone H3 acetylation

(2011) Chuanbing Bian et al.   EMBO JOURNAL

Intrinsic transition of embryonic stem-cell differentiation into neural progenitors

(2011) Daisuke Kamiya et al.   NATURE

Concise Review: Oct4 and More: The Reprogramming Expressway

(2011) Jared Sterneckert et al.   STEM CELLS

Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway

(2010) Xiao Qi Wang et al.   HEPATOLOGY

CD13 is a therapeutic target in human liver cancer stem cells

(2010) Naotsugu Haraguchi et al.   JOURNAL OF CLINICAL INVESTIGATION

Expression of Oct4 in HCC and modulation to wnt/β-catenin and TGF-β signal pathways

(2010) FangJun Yuan et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

(2010) A Singh et al.   ONCOGENE

Oct4-Induced Pluripotency in Adult Neural Stem Cells

(2009) Jeong Beom Kim et al.   CELL

The transcriptional foundation of pluripotency

(2009) I. Chambers et al.   DEVELOPMENT

A novel SRY missense mutation affecting nuclear import in a 46,XY female patient with bilateral gonadoblastoma

(2009) Remko Hersmus et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

A cell-autonomous role for WT1 in regulating Sry in vivo

(2009) S. T. Bradford et al.   HUMAN MOLECULAR GENETICS

Influence of fetal calf serum on differentiation of mesenchymal stem cells to chondrocytes during expansion

(2008) Mari Yokoyama et al.   JOURNAL OF BIOSCIENCE AND BIOENGINEERING

The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells

(2008) Scott Bidlingmaier et al.   JOURNAL OF MOLECULAR MEDICINE-JMM